Wei Xue

Department of Urology, Shanghai Jiao Tong University School of Medicine

Affiliated withShanghai Jiao Tong University School of Medicine

Research Area

Biography

Wei Xue has not added Biography.
If you are Wei Xue and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56Â months. Familial cancer\| PubMed ID: 22203439	2011
Application of a standardized anatomical classification in a Chinese partial nephrectomy series. International journal of urology : official journal of the Japanese Urological Association\| PubMed ID: 22462720	2012
Primitive neuroectodermal tumor of the kidney: a single-institute series of six patients from China. Urologia internationalis\| PubMed ID: 23108259	2013
Application of ¹H NMR metabonomics in predicting renal function recoverability after the relief of obstructive uropathy in adult patients. Clinical biochemistry\| PubMed ID: 23195136	2013
Diagnostic value of N-acetyl-β-D-glucosaminidase for the early prediction of acute kidney injury after percutaneous nephrolithotripsy. Experimental and therapeutic medicine\| PubMed ID: 23251267	2013
Molecular insights into the development of T cell-based immunotherapy for prostate cancer. Expert review of clinical immunology\| PubMed ID: 25259804	2014
The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker. The Prostate\| PubMed ID: 27272765	2016
Significant differences in struvite and cystine stone frequency seen among Chinese nephrolithiasis patients living in North America compared to those living in China. Translational andrology and urology\| PubMed ID: 27298786	2016
SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis. Oncotarget\| PubMed ID: 27741516	2016
AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis. The Journal of clinical investigation\| PubMed ID: 28319045	2017
Peritumoral Artery Scoring System: a Novel Scoring System to Predict Renal Function Outcome after Laparoscopic Partial Nephrectomy. Scientific reports\| PubMed ID: 28588259	2017
Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy-naive metastatic castration-resistant prostate cancer. The Prostate\| PubMed ID: 28804908	2017
Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration-resistant prostate cancer. The Prostate\| PubMed ID: 30614033	2019
Recent advances in extracellular vesicle research for urological cancers: From technology to application. Biochimica et biophysica acta. Reviews on cancer\| PubMed ID: 30738098	2019
Metastatic prostate cancer remains incurable, why? Asian journal of urology\| PubMed ID: 30775246	2019
SUMO-Specific Protease 1 Is Critical for Myeloid-Derived Suppressor Cell Development and Function. Cancer research\| PubMed ID: 31186231	2019
The combination of size-based separation and selection-free technology provides higher circulating tumour cells detection sensitivity than either method alone in patients with metastatic pro... BJU international\| PubMed ID: 32115854	2020
P53 suppresses SENP3 phosphorylation to mediate G2 checkpoint. Cell discovery\| PubMed ID: 32351703	2020
Comparison of three dimensional reconstruction and conventional computer tomography angiography in patients undergoing zero-ischemia laparoscopic partial nephrectomy. BMC medical imaging\| PubMed ID: 32375663	2020
The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma. Cell proliferation\| PubMed ID: 32537867	2020
Thermal ablation assisted laparoscopic partial nephrectomy for clinical T1b renal tumors. Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy\| PubMed ID: 32687004	2022
Prospective evaluation of Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time aft... Medical oncology (Northwood, London, England)\| PubMed ID: 32920666	2020
Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium. Journal of extracellular vesicles\| PubMed ID: 33489012	2020
High-Throughput Simultaneous mRNA Profiling Using nCounter Technology Demonstrates That Extracellular Vesicles Contain Different mRNA Transcripts Than Their Parental Prostate Cancer Cells. Analytical chemistry\| PubMed ID: 33596381	2021
SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis. Nature communications\| PubMed ID: 33753739	2021
The characteristics and risk factors of healthcare-seeking men with lower urinary tract symptoms in China: Initial report from the POInT group. Neurourology and urodynamics\| PubMed ID: 34252243	2021
Glucose limitation activates AMPK coupled SENP1-Sirt3 signalling in mitochondria for T cell memory development. Nature communications\| PubMed ID: 34272364	2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine\| PubMed ID: 34326128	2022
The Clinical Features and Predictive Factors of Nocturnal Enuresis in Adult Women. Frontiers in medicine\| PubMed ID: 35111771	2021
Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystec... International journal of nanomedicine\| PubMed ID: 35411143	2022
SENP1-Sirt3 signaling promotes α-ketoglutarate production during M2 macrophage polarization. Cell reports\| PubMed ID: 35417703	2022
Correction: Tumor-educated B cells promote renal cancer metastasis via inducing the IL-1β/HIF-2α/Notch1 signals. Cell death & disease\| PubMed ID: 35487904	2022
Olaparib for Chinese metastatic castration-resistant prostate cancer: A real-world study of efficacy and gene predictive analysis. Medical oncology (Northwood, London, England)\| PubMed ID: 35599270	2022
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer. Nature cancer\| PubMed ID: 35624341	2022
Squalene Epoxidase Metabolic Dependency Is a Targetable Vulnerability in Castration-Resistant Prostate Cancer. Cancer research\| PubMed ID: 35767703	2022
VHL and DNA damage repair pathway alterations as potential clinical biomarkers for first-line TKIs in metastatic clear cell renal cell carcinomas. Cellular oncology (Dordrecht, Netherlands)\| PubMed ID: 35834099	2022
Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Theranostics\| PubMed ID: 35836810	2022
Clinicopathologic, treatment and prognosis study of 46 Xp11.2 translocation/TFE3 gene fusion renal cell carcinomas. BMC urology\| PubMed ID: 35850864	2022
Diagnosis of urogenital cancer combining deep learning algorithms and surface-enhanced Raman spectroscopy based on small extracellular vesicles. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy\| PubMed ID: 35868057	2022
Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation. Frontiers in oncology\| PubMed ID: 36033483	2022
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine ch... Oncoimmunology\| PubMed ID: 36148322	2022
Prostate-Specific Membrane Antigen-Based PET Brings New Insights into the Management of Prostate Cancer. PET clinics\| PubMed ID: 36153235	2022
Prostate cancer treatment - China's perspective. Cancer letters\| PubMed ID: 36162714	2022
Surgical Management and Oncologic Outcomes for Local Retroperitoneal Recurrence of Renal Cell Carcinoma After Radical Nephrectomy. Clinical genitourinary cancer\| PubMed ID: 36396584	2023
RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients. Materials today. Bio\| PubMed ID: 36425924	2022
Acute kidney injury as an independent predicting factor for stage 3 or higher chronic kidney disease after nephrectomy. Urologic oncology\| PubMed ID: 36463084	2023
PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study. Asian journal of andrology\| PubMed ID: 36537376	2023
TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer. Oncogene\| PubMed ID: 36544044	2023
Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinoma. Precision clinical medicine\| PubMed ID: 36544542	2022
The application of "S.I.S" technique improves long-term continence after robotic radical prostatectomy. Neurourology and urodynamics\| PubMed ID: 36705067	2023
Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. Cell reports\| PubMed ID: 36724072	2023
Multimodal convolutional neural networks based on the Raman spectra of serum and clinical features for the early diagnosis of prostate cancer. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy\| PubMed ID: 36787677	2023
The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy. Journal of clinical medicine\| PubMed ID: 36835879	2023
In vivo detection demonstrates circulating tumor cell reduction instead of baseline number has prognostic value in bladder cancer patients receiving neoadjuvant chemotherapy. Cellular oncology (Dordrecht, Netherlands)\| PubMed ID: 36877311	2023
In vivo detection of circulating tumor cells predicts high-risk features in patients with bladder cancer. Medical oncology (Northwood, London, England)\| PubMed ID: 36884136	2023
Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer. Cancer research and treatment\| PubMed ID: 36915250	2023
Engineering the MoS /MXene Heterostructure for Precise and Noninvasive Diagnosis of Prostate Cancer with Clinical Specimens. Advanced science (Weinheim, Baden-Wurttemberg, Germany)\| PubMed ID: 36988431	2023
The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy. International urology and nephrology\| PubMed ID: 37017821	2023
Identification of cancer-associated fibroblasts subtypes in prostate cancer. Frontiers in immunology\| PubMed ID: 37033924	2023
IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany)\| PubMed ID: 37092583	2023
Repurposing ketotifen as a therapeutic strategy for neuroendocrine prostate cancer by targeting the IL-6/STAT3 pathway. Cellular oncology (Dordrecht, Netherlands)\| PubMed ID: 37120492	2023
Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy. The Prostate\| PubMed ID: 37165552	2023
F-FDG PET/CT imaging in neuroendocrine prostate cancer: Relation to histopathology and prognosis. The Prostate\| PubMed ID: 37189301	2023
Adjustable continence therapy (proACT) for the treatment of male stress urinary incontinence post-prostatectomy: a systematic review and meta-analysis (2023 update). World journal of urology\| PubMed ID: 37311990	2023
Serum extracellular vesicles derived hsa-miR-320d as an indicator for progression of clear cell renal cell carcinoma. Discover oncology\| PubMed ID: 37380801	2023
Loss of MIR503HG facilitates papillary renal cell carcinoma associated lymphatic metastasis by triggering NOTCH1/VEGFC signaling. International journal of biological sciences\| PubMed ID: 37416763	2023
Comparative analysis of salvage partial nephrectomy versus radical nephrectomy after the failure of initial partial nephrectomy. Urologic oncology\| PubMed ID: 37563078	2023
Clinical outcomes of immune checkpoint inhibitor plus nab-paclitaxel in metastatic upper tract urothelial carcinoma. Translational andrology and urology\| PubMed ID: 37814696	2023
Retroperitoneoscopic Clampless, Sutureless Hybrid Therapy in the Management of Renal Hilar Tumors. Annals of surgical oncology\| PubMed ID: 37903952	2024
The ELAVL3/MYCN positive feedback loop provides a therapeutic target for neuroendocrine prostate cancer. Nature communications\| PubMed ID: 38016952	2023
ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers. The Journal of clinical investigation\| PubMed ID: 38099497	2023
Extracellular vesicles related gene HSPH1 exerts anti-tumor effects in prostate cancer via promoting the stress response of CD8 + T cells. Cellular oncology (Dordrecht, Netherlands)\| PubMed ID: 38165608	2024
Precise diagnosis and risk stratification of prostate cancer by comprehensive serum metabolic fingerprints: a prediction model study. International journal of surgery (London, England)\| PubMed ID: 38181121	2024
Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer. Journal of extracellular vesicles\| PubMed ID: 38293707	2024
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Research square\| PubMed ID: 38585988	2024
Harnessing artificial intelligence for prostate cancer management. Cell reports. Medicine\| PubMed ID: 38593808	2024
The Role of Extracellular Vesicles in the Treatment of Prostate Cancer. Small (Weinheim an der Bergstrasse, Germany)\| PubMed ID: 38639331	2024
CDCA5-EEF1A1 interaction promotes progression of clear cell renal cell carcinoma by regulating mTOR signaling. Cancer cell international\| PubMed ID: 38658931	2024
SERSomes for metabolic phenotyping and prostate cancer diagnosis. Cell reports. Medicine\| PubMed ID: 38776910	2024
Mendelian randomization evidence based on European ancestry for the causal effects of leukocyte telomere length on prostate cancer. Human genomics\| PubMed ID: 38831447	2024
Urinary extracellular vesicle-derived miR-126-3p predicts lymph node invasion in patients with high-risk prostate cancer. Medical oncology (Northwood, London, England)\| PubMed ID: 38839666	2024
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers. Nature cancer\| PubMed ID: 39242942	2024
Neoadjuvant everolimus in renal angiomyolipoma with or without tuberous sclerosis complex: Results from a multicenter, retrospective study. Cancer medicine\| PubMed ID: 39279295	2024
Publisher Correction: Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers. Nature cancer\| PubMed ID: 39354226	2024
Prognostic value of [F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort study. Annals of medicine\| PubMed ID: 39392016	2024
Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer. Nature communications\| PubMed ID: 39426954	2024
Efficacy and Predictive Factors Analysis of Androgen Deprivation Plus Novel Hormone Therapy as Neoadjuvant Treatment for High-Risk Prostate Cancer. The Prostate\| PubMed ID: 39488849	2025
Disruption of circadian rhythm as a potential pathogenesis of nocturia. Nature reviews. Urology\| PubMed ID: 39543359	2025
Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian Men. Journal of the National Comprehensive Cancer Network : JNCCN\| PubMed ID: 39546889	2024
AGD1/USP10/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer. Journal of experimental & clinical cancer research : CR\| PubMed ID: 39806412	2025
Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathway. Cancer letters\| PubMed ID: 39894195	2025
5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis. The Journal of clinical investigation\| PubMed ID: 39903533	2025
Correction to: Urinary extracellular vesicle‑derived miR‑126‑3p predicts lymph node invasion in patients with high‑risk prostate cancer. Medical oncology (Northwood, London, England)\| PubMed ID: 40117067	2025
Reply to 'The disruption of circadian rhythm as a potential mechanism of nocturia-like symptoms - a paediatric urology perspective'. Nature reviews. Urology\| PubMed ID: 40169836	2025
Development and Validation of the UriMee Model: A Methylation-based Diagnostic Tool for Early Diagnosis of Urothelial Carcinoma. European urology oncology\| PubMed ID: 40240254	2025
Clinical Outcomes and Safety Profile of Neoadjuvant PD-1 Inhibitors Combined With VEGFR-TKI Versus VEGFR-TKI in Nonmetastatic Renal Cell Carcinoma. Clinical genitourinary cancer\| PubMed ID: 40348728	2025
Erdafitinib versus Chemotherapy in Fibroblast Growth Factor Receptor-Altered Advanced or Metastatic Urothelial Cancer After Progression on Anti-programmed Death-(Ligand) 1 Therapy: An Explor... Clinical genitourinary cancer\| PubMed ID: 40483179	2025
O-GalNAc Glycosylation Activates MBL-Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis. Advanced science (Weinheim, Baden-Wurttemberg, Germany)\| PubMed ID: 40492591	2025
The molecular axis hnRNPU/circKCNK2/EDC4/IL-11 aggravates osteolytic bone metastasis of RCC. Oncogene\| PubMed ID: 40640337	2025
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study. Cancer immunology, immunotherapy : CII\| PubMed ID: 40944727	2025
Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer. Journal of experimental & clinical cancer research : CR\| PubMed ID: 41152972	2025
Comparison of 5 T and 3 T Biparametric MRI for Clinically Suspected Prostate Cancer: Image Quality, Lesion Visualization, and Artifacts. Journal of magnetic resonance imaging : JMRI\| PubMed ID: 41221770	2025